Bardy Diagnostics Inc.

Bellevue, WA Part of Baxter Healthcare Corporation

UEI
EN3KMR6DVLY5
CAGE
809A4
Primary NAICS
334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Baxter Healthcare Corporation, ranks:

and 6 more

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
  • Baxter Health Systems Parent Baxter Healthcare Corporation · Deerfield, IL RSKLEFCZ6127
    • Bardy Diagnostics Inc.
SAM.gov registration date
Physical address
220 120th Ave NE, Bellevue, WA 98005, USA
Website
bardydx.com
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $34,950
FY2024 $34,925
FY2023 $34,775

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Bardy Diagnostics Inc. is a for-profit corporate entity based in Bellevue, Washington, specializing in ambulatory electrocardiogram (ECG) monitoring solutions. The company has been registered in SAM.gov since November 28, 2017, with its registration set to expire on May 1, 2026. While specific details about the company's founding or complete background are not provided, the federal contract award history indicates that Bardy Diagnostics focuses on developing and supplying advanced cardiac monitoring technologies, particularly their Carnation Ambulatory Monitor (CAM) product line.

Over the past several years, Bardy Diagnostics Inc. has consistently secured federal contract awards primarily from the Defense Health Agency (DHA) and the National Heart, Lung, and Blood Institute, predominantly for the supply of cardiac monitoring equipment. These purchase order contracts, ranging in value from $17,500 to $34,949.95, have been for various types of heart monitors and monitor patches, including short-term and long-term ambulatory ECG monitors designed for extended wear periods up to 14 days. The contracts are typically firm fixed-price and not associated with any set-aside programs, suggesting the company competes in the open market. The contract descriptions indicate the monitors are used for clinical studies, pediatric applications, and cardiac arrhythmia monitoring, primarily serving Department of Defense health facilities. None of the awards indicate the use of subcontractors, implying Bardy Diagnostics serves as the prime contractor in these federal procurement transactions.

Quick answers

Is Bardy Diagnostics Inc. registered in SAM.gov?

Yes. Bardy Diagnostics Inc.'s SAM.gov registration is active through March 31, 2027.

How much has Bardy Diagnostics Inc. received in federal contracts?

Federal contracts obligated $34,950 to Bardy Diagnostics Inc. in fiscal year 2025 and $104,650 in fiscal years 2023 through 2027.

How does Bardy Diagnostics Inc. rank among federal contractors?

Bardy Diagnostics Inc.'s parent company, Baxter Healthcare Corporation, ranked #10 in NAICS 325411, #20 in NAICS 456199 and #23 in NAICS 45619 in FY2025.

What is Bardy Diagnostics Inc.'s most recent federal award?

Bardy Diagnostics Inc.'s most recent federal contract award is Heart monitors (HT001425P0037), from Defense Health Agency, on January 22, 2025.

On GovTribe

See Bardy Diagnostics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors